Company Overview of Nano Sanguis S.A.
Nano Sanguis S.A. develops red blood cell substitutes for oxygen therapeutics. The company develops synthetic oxygen carriers that substitute natural blood for transfusions and organs transport. Nano Sanguis S.A. was founded in 2015 and is based in Warsaw, Poland.
Ludwika Warynskiego 1
Founded in 2015
Key Executives for Nano Sanguis S.A.
Similar Private Companies By Industry
|AlgaeLabs Sp. z o.o||Europe|
|Beta Bio Technology sp. z o.o.||Europe|
|Bioavlee Sp. z o.o.||Europe|
|BIOCORP Polska Sp. z o.o.||Europe|
|BioVentures Institute Sp. z o.o.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Nano Sanguis S.A., please visit nanosanguis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.